Works matching DE "CHRONIC myeloid leukemia"


Results: 5000
    1
    2

    Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 11, p. 3695, doi. 10.3390/jcm14113695
    By:
    • Tangkitchot, Jirapath;
    • Tantiworawit, Adisak;
    • Niprapan, Piangrawee;
    • Wongsarikan, Nuttanun;
    • Srichairatanakool, Sirichai;
    • Punnachet, Teerachat;
    • Hantrakun, Nonthakorn;
    • Piriyakhuntorn, Pokpong;
    • Rattanathammethee, Thanawat;
    • Chai-Adisaksopha, Chatree;
    • Rattarittamrong, Ekarat;
    • Norasetthada, Lalita;
    • Hantrakool, Sasinee
    Publication type:
    Article
    3
    4
    5

    Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent.

    Published in:
    Cell Biology International, 2025, v. 49, n. 5, p. 570, doi. 10.1002/cbin.70007
    By:
    • Cavalleri, Alessia;
    • Xhahysa, Besjana;
    • Mutti, Silvia;
    • Ferraro, Rosalba Monica;
    • Mazzoldi, Elena Laura;
    • Farina, Mirko;
    • Leoni, Alessandro;
    • Garuffo, Luca;
    • Trenta, Federica;
    • Re, Federica;
    • Radici, Vera;
    • Buttini, Eugenia Accorsi;
    • Morello, Enrico;
    • Magliano, Gabriele;
    • Cancelli, Valeria;
    • Giliani, Silvia Clara;
    • Malagola, Michele;
    • Russo, Domenico;
    • Bernardi, Simona
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Test Your Image IQ.

    Published in:
    Oncology (08909091), 2012, v. 26, n. 9, p. 819
    Publication type:
    Article
    24
    26
    27

    When Imatinib Fails.

    Published in:
    Oncology (08909091), 2008, v. 22, n. 4, p. 448
    By:
    • Stone, Richard
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 1, p. 114, doi. 10.2298/VSP180723010D
    By:
    • Denčić-Fekete, Marija;
    • Leković, Danijela;
    • Djordjević, Vesna;
    • Jovanović, Jelica;
    • Todorić-Živanović, Biljana;
    • Jaković, Ljubomir;
    • Bogdanović, Andrija
    Publication type:
    Article
    38
    39
    40
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

    Published in:
    European Journal of Clinical Pharmacology, 2020, v. 76, n. 9, p. 1213, doi. 10.1007/s00228-020-02910-3
    By:
    • Boons, Christel C. L. M.;
    • Timmers, Lonneke;
    • Janssen, Jeroen J. W. M.;
    • Westerweel, Peter E.;
    • Blijlevens, Nicole M. A.;
    • Smit, Willem M.;
    • Bartelink, Imke H.;
    • Wilschut, Janneke A.;
    • Swart, Eleonora L.;
    • Hendrikse, N. Harry;
    • Hugtenburg, Jacqueline G.
    Publication type:
    Article